{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:01:59Z","timestamp":1793289719824,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04064-x","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:13:07Z","timestamp":1722571987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Early anti-coagulation therapy in new-onset atrial fibrillation after coronary artery bypass grafting: a randomized trial pilot study"],"prefix":"10.1186","volume":"24","author":[{"given":"Mojgan","family":"Ghavami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Abdshah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahryar Rajai Firouz","family":"Abadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diba","family":"Akbarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin","family":"Kalhor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"12","key":"4064_CR1","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1136\/heartjnl-2017-312150","volume":"104","author":"G Filardo","year":"2018","unstructured":"Filardo G, Damiano RJ Jr., Ailawadi G, Thourani VH, Pollock BD, Sass DM, et al. Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery. Heart. 2018;104(12):985\u201392.","journal-title":"Heart"},{"issue":"1","key":"4064_CR2","doi-asserted-by":"publisher","first-page":"e017966","DOI":"10.1161\/JAHA.120.017966","volume":"10","author":"A Taha","year":"2021","unstructured":"Taha A, Nielsen SJ, Bergfeldt L, Ahlsson A, Friberg L, Bjorck S, et al. New-Onset Atrial Fibrillation after coronary artery bypass grafting and long-term outcome: a Population-based Nationwide Study from the SWEDEHEART Registry. J Am Heart Assoc. 2021;10(1):e017966.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"4064_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/ejcts\/ezy028","volume":"54","author":"TA Schwann","year":"2018","unstructured":"Schwann TA, Al-Shaar L, Engoren MC, Bonnell MR, Goodwin M, Schwann AN, Habib RH. Effect of new-onset atrial fibrillation on cause-specific late mortality after coronary artery bypass grafting surgery. Eur J Cardiothorac Surg. 2018;54(2):294\u2013301.","journal-title":"Eur J Cardiothorac Surg"},{"key":"4064_CR4","doi-asserted-by":"crossref","unstructured":"Wolf P, Abbott RJS, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. 1991;22(8):983\u20138.","DOI":"10.1161\/01.STR.22.8.983"},{"key":"4064_CR5","doi-asserted-by":"publisher","first-page":"803233","DOI":"10.3389\/fcvm.2022.803233","volume":"9","author":"PH Liu","year":"2022","unstructured":"Liu PH, Liu ZH, Niu MH, Chen P, Shi YB, He F, Guo R. A comparative study of the clinical benefits of Rivaroxaban and Warfarin in patients with non-valvular atrial fibrillation with high bleeding risk. Front Cardiovasc Med. 2022;9:803233.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"4064_CR6","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3390\/life13061260","volume":"13","author":"G Leventopoulos","year":"2023","unstructured":"Leventopoulos G, Koros R, Travlos C, Perperis A, Chronopoulos P, Tsoni E, et al. Mechanisms of Atrial Fibrillation: how our knowledge affects clinical practice. Life. 2023;13(6):1260.","journal-title":"Life"},{"issue":"17","key":"4064_CR7","doi-asserted-by":"publisher","first-page":"407","DOI":"10.21037\/atm.2019.07.10","volume":"7","author":"PS Jagadish","year":"2019","unstructured":"Jagadish PS, Kirolos I, Khare S, Rawal A, Lin V, Khouzam RN. Post-operative atrial fibrillation: should we anticoagulate? Annals Translational Med. 2019;7(17):407.","journal-title":"Annals Translational Med"},{"issue":"5","key":"4064_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"1","key":"4064_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice guidelines. Circulation. 2024;149(1):e1\u2013156.","journal-title":"Circulation"},{"key":"4064_CR10","doi-asserted-by":"crossref","unstructured":"Macle L, Cairns J, Leblanc K, Tsang T, Skanes A, Cox J, for the CCS Atrial Fibrillation Guidelines Committee. 2016 focused update of the Canadian Cardiovascular Society Guidelines for the management of Atrial Fibrillation. 2016;32(10):1170\u201385.","DOI":"10.1016\/j.cjca.2016.07.591"},{"issue":"3","key":"4064_CR11","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1016\/j.jtcvs.2014.06.036","volume":"148","author":"G Frendl","year":"2014","unstructured":"Frendl G, Sodickson AC, Chung MK, Waldo AL, Gersh BJ, Tisdale JE, et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg. 2014;148(3):e153\u201393.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"4064_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1477-9560-11-11","volume":"11","author":"MM Samama","year":"2013","unstructured":"Samama MM, Contant G, Spiro TE, Perzborn E, Le Flem L, Guinet C, et al. Laboratory assessment of rivaroxaban: a review. Thromb J. 2013;11(1):11.","journal-title":"Thromb J"},{"issue":"6","key":"4064_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1182\/blood-2018-01-830901","volume":"132","author":"S Wu","year":"2018","unstructured":"Wu S, Chen X, Jin DY, Stafford DW, Pedersen LG, Tie JK. Warfarin and vitamin K epoxide reductase: a molecular accounting for observed inhibition. Blood. 2018;132(6):647\u201357.","journal-title":"Blood"},{"key":"4064_CR14","unstructured":"Antithrombotic Therapy for Patients With Atrial Fibrillation. CADTH Report \/ Project in Briefs. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. Copyright \u00a9 2011- CADTH.; 2011."},{"issue":"29","key":"4064_CR15","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1093\/eurheartj\/ehy369","volume":"39","author":"H Poorhosseini","year":"2018","unstructured":"Poorhosseini H, Abbasi SH. The Tehran Heart Center. Eur Heart J. 2018;39(29):2695\u20136.","journal-title":"Eur Heart J"},{"issue":"9","key":"4064_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/clc.22435","volume":"38","author":"W Zhu","year":"2015","unstructured":"Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED score for Predicting Major bleeding risk in anticoagulated patients with Atrial Fibrillation: a systematic review and Meta-analysis. Clin Cardiol. 2015;38(9):555\u201361.","journal-title":"Clin Cardiol"},{"issue":"1","key":"4064_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31\u201341.","journal-title":"Nephron"},{"issue":"4","key":"4064_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Statistics: J Appl Stat Pharm Ind. 2005;4(4):287\u201391.","journal-title":"Pharm Statistics: J Appl Stat Pharm Ind"},{"issue":"2","key":"4064_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/nur.20247","volume":"31","author":"MA Hertzog","year":"2008","unstructured":"Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health. 2008;31(2):180\u201391.","journal-title":"Res Nurs Health"},{"issue":"1","key":"4064_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-10-67","volume":"10","author":"M Arain","year":"2010","unstructured":"Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10(1):1\u20137.","journal-title":"BMC Med Res Methodol"},{"key":"4064_CR21","doi-asserted-by":"crossref","unstructured":"Pinheiro NC, Lopes A, Camoes A, Monteiro MS. Spontaneous subcutaneous tissue haematoma associated with warfarin. BMJ Case Rep. 2016;2016:10 1136\/bcr-2016-215134.","DOI":"10.1136\/bcr-2016-215134"},{"issue":"13","key":"4064_CR22","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.jacc.2009.10.058","volume":"55","author":"MF El-Chami","year":"2010","unstructured":"El-Chami MF, Kilgo P, Thourani V, Lattouf OM, Delurgio DB, Guyton RA, et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. J Am Coll Cardiol. 2010;55(13):1370\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4064_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.amjcard.2011.08.033","volume":"109","author":"A Saxena","year":"2012","unstructured":"Saxena A, Dinh DT, Smith JA, Shardey GC, Reid CM, Newcomb AE. Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients). Am J Cardiol. 2012;109(2):219\u201325.","journal-title":"Am J Cardiol"},{"issue":"4","key":"4064_CR24","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/00000658-199710000-00011","volume":"226","author":"GH Almassi","year":"1997","unstructured":"Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg. 1997;226(4):501\u201311. discussion 11\u2009\u2013\u20093.","journal-title":"Ann Surg"},{"issue":"12","key":"4064_CR25","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/eurheartj\/ehad019","volume":"44","author":"M Gaudino","year":"2023","unstructured":"Gaudino M, Di Franco A, Rong LQ, Piccini J, Mack M. Postoperative atrial fibrillation: from mechanisms to treatment. Eur Heart J. 2023;44(12):1020\u201339.","journal-title":"Eur Heart J"},{"issue":"6","key":"4064_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/1074248420929483","volume":"25","author":"TW Chapin","year":"2020","unstructured":"Chapin TW, Leedahl DD, Brown AB, Pasek AM, Sand MG, Loy ML, Dyke CM. Comparison of anticoagulants for Postoperative Atrial Fibrillation after coronary artery bypass grafting: a pilot study. J Cardiovasc Pharmacol Therap. 2020;25(6):523\u201330.","journal-title":"J Cardiovasc Pharmacol Therap"},{"issue":"5","key":"4064_CR27","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.athoracsur.2020.12.031","volume":"112","author":"V Nauffal","year":"2021","unstructured":"Nauffal V, Trinquart L, Osho A, Sundt TM, Lubitz SA, Ellinor PT. Non-vitamin K antagonist oral anticoagulant vs warfarin for Post Cardiac surgery Atrial Fibrillation. Ann Thorac Surg. 2021;112(5):1392\u2013401.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"4064_CR28","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.amjsurg.2015.07.005","volume":"210","author":"E Anderson","year":"2015","unstructured":"Anderson E, Johnke K, Leedahl D, Glogoza M, Newman R, Dyke C. Novel oral anticoagulants vs warfarin for the management of postoperative atrial fibrillation: clinical outcomes and cost analysis. Am J Surg. 2015;210(6):1095\u2013102. discussion 102-3.","journal-title":"Am J Surg"},{"issue":"10","key":"4064_CR29","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883\u201391.","journal-title":"N Engl J Med"},{"issue":"3","key":"4064_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5761\/atcs.oa.20-00213","volume":"27","author":"A Sezai","year":"2021","unstructured":"Sezai A, Taoka M, Osaka S, Kitazumi Y, Suzuki K, Kamata K, Tanaka M. A comparative prospective observational study on the use of direct oral anticoagulants after cardiac surgery for the management of Atrial Fibrillation. Annals Thorac Cardiovasc Surgery: Official J Association Thorac Cardiovasc Surg Asia. 2021;27(3):191\u20139.","journal-title":"Annals Thorac Cardiovasc Surgery: Official J Association Thorac Cardiovasc Surg Asia"},{"issue":"5","key":"4064_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jamacardio.2018.0405","volume":"3","author":"JH Butt","year":"2018","unstructured":"Butt JH, Xian Y, Peterson ED, Olsen PS, Rorth R, Gundlund A, et al. Long-term thromboembolic risk in patients with postoperative atrial Fibrillation after coronary artery bypass graft surgery and patients with Nonvalvular Atrial Fibrillation. JAMA Cardiol. 2018;3(5):417\u201324.","journal-title":"JAMA Cardiol"},{"issue":"2","key":"4064_CR32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/STROKEAHA.119.025554","volume":"51","author":"M Alberts","year":"2020","unstructured":"Alberts M, Chen YW, Lin JH, Kogan E, Twyman K, Milentijevic D. Risks of stroke and mortality in Atrial Fibrillation patients treated with Rivaroxaban and Warfarin. Stroke. 2020;51(2):549\u201355.","journal-title":"Stroke"},{"key":"4064_CR33","doi-asserted-by":"crossref","unstructured":"Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R, Lakkireddy D, Dominic P. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace: European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2018;20(1):33\u201342.","DOI":"10.1093\/europace\/eux013"},{"issue":"5","key":"4064_CR34","first-page":"638","volume":"14","author":"J Zhuang","year":"2012","unstructured":"Zhuang J, Wang Y, Tang K, Li X, Peng W, Liang C, Xu Y. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. Europace: Eur Pacing Arrhythm Cardiac Electrophysiol : J Working Groups Cardiac Pacing Arrhythm Cardiac Cell Electrophysiol Eur Soc Cardiol. 2012;14(5):638\u201345.","journal-title":"Europace: Eur Pacing Arrhythm Cardiac Electrophysiol : J Working Groups Cardiac Pacing Arrhythm Cardiac Cell Electrophysiol Eur Soc Cardiol"},{"issue":"1","key":"4064_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13019-019-0881-3","volume":"14","author":"N Al-Attar","year":"2019","unstructured":"Al-Attar N, Johnston S, Jamous N, Mistry S, Ghosh E, Gangoli G, et al. Impact of bleeding complications on length of stay and critical care utilization in cardiac surgery patients in England. J Cardiothorac Surg. 2019;14(1):64.","journal-title":"J Cardiothorac Surg"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04064-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04064-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04064-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:15:13Z","timestamp":1722572113000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04064-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4064"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04064-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from each patient before recruitment and the study protocol was reviewed and approved by the ethical committees of the Tehran University of Medical Sciences with the code of: \u201cIR.TUMS.MEDICINE.REC.1398.836\u201d. The trial was also registered in IRCT with code \u201cIRCT20200304046696N1\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"404"}}